Jiuxiang Zhu

A frequent kinase domain mutation that changes the interaction between PI3Kα and the membrane

Diana Mandelker, Sandra B. Gabelli, Oleg Schmidt‐Kittler et al. · Proceedings of the National Academy of Sciences · 2009 · 296 citations · Full text

Medicine, Molecular Biology, Oncology +17

From the Cyclooxygenase-2 Inhibitor Celecoxib to a Novel Class of 3-Phosphoinositide-Dependent Protein Kinase-1 Inhibitors

Jiuxiang Zhu, Jui-Wen Huang, Ping‐Hui Tseng et al. · Cancer Research · 2004 · 256 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +15

Neutrophil gelatinase-associated lipocalin as a survival factor

Zhimin Tong, Xuli Wu, Dmitriy Ovcharenko et al. · Biochemical Journal · 2005 · 186 citations · Full text

Medicine, Oncology, Pharmacology +17

Celecoxib derivatives induce apoptosis <i>via</i> the disruption of mitochondrial membrane potential and activation of caspase 9

Haiming Ding, Chunhua Han, Jiuxiang Zhu et al. · International Journal of Cancer · 2004 · 110 citations · Full text

Medicine, Oncology, Pharmacology +15

Celecoxib analogues disrupt Akt signaling, which is commonly activated in primary breast tumours

Jill E. Kucab, Cathy Lee, Ching‐Shih Chen et al. · Breast Cancer Research · 2005 · 93 citations · Full text

Medicine, Oncology, Pharmacology +14